Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine

Fang L.I. Ang, Andrew Rowland, Natansh D. Modi, Ross A. McKinnon, Michael J. Sorich, Ashley M. Hopkins

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)
38 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science